HUMABIOLOGICS, INC. — Form D
HUMABIOLOGICS, INC. of PHOENIX, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-29. The offering totals $1.0M, of which $25K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-01-29
- Form: D
- Accession: 0001801256-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $25K
- Remaining: $975K
- Minimum investment: $5K
- Investors: 1
- Date of first sale: 2020-01-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-359169
Issuer
- Name: HUMABIOLOGICS, INC.
- CIK: 0001801256
- Entity type: Corporation
- Jurisdiction: ARIZONA
- Incorporated: 2018
- Address: 275 N GATEWAY DRIVE, PHOENIX, AZ, 85034
- Phone: (602) 786-6289
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Mohammad Albanna | Director | Phoenix, AZ |
| Mohammad Albanna | Executive Officer | Phoenix, AZ |
| Dan Mahaffey | Executive Officer | Phoenix, AZ |
Other filings by this issuer (1)
More